New weapon to curb smoking: no more excuses to delay treatment.
Johnson
Bankole A
BA
D001552:Benzazepines / Q000627:therapeutic use*; D005632:Fructose / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use; D009538:Nicotine / Q000009:adverse effects; D018722:Nicotinic Agonists / Q000627:therapeutic use*; D018733:Nicotinic Antagonists / Q000627:therapeutic use*; D011810:Quinoxalines / Q000627:therapeutic use*; D016540:Smoking Cessation / Q000379:methods*; D014029:Tobacco Use Disorder / Q000188:drug therapy*; D000077236:Topiramate; D000068580:Varenicline
D001552:Benzazepines; D018696:Neuroprotective Agents; D018722:Nicotinic Agonists; D018733:Nicotinic Antagonists; D011810:Quinoxalines; D000077236:Topiramate; D005632:Fructose; D009538:Nicotine; D000068580:Varenicline